VORICONAZOLE-ZP voriconazole 200mg tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

voriconazole, Quantity: 200 mg

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

Voriconazole

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; microcrystalline cellulose; povidone; titanium dioxide; hypromellose; triacetin; macrogol 3350

Verabreichungsweg:

Oral

Einheiten im Paket:

30, 100, 56, 10, 20, 50, 2, 14, 28

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

VORICONAZOLE-ZP is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Produktbesonderheiten:

Visual Identification: white, oval biconvex tablets, debossed 'VC200' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-02-02